ByeAcne/Medication
Winlevi vs Spironolactone
Winlevi is the first topical androgen-receptor blocker — a localized hormonal acne treatment without the systemic effects of spironolactone. Different trade-offs.
Reviewed by a licensed physician · Updated May 2026
Winlevi (clascoterone 1% cream) is the first topical androgen-receptor inhibitor for acne, FDA-approved in 2020. It opened a new treatment category — topical hormonal acne treatment — that previously didn't exist. For patients who would benefit from androgen blockade but can't or don't want to take systemic spironolactone, Winlevi is meaningfully important.
The mechanism: clascoterone is structurally similar to spironolactone and blocks androgen receptors at sebaceous glands. The difference is delivery — applied topically, it acts locally where applied without significant systemic absorption. Sebum production decreases at the application site without altering circulating hormone levels.
This topical approach has specific advantages over spironolactone. First, it works in men: spironolactone is rarely used in men because its systemic anti-androgen effects can cause gynecomastia (breast tissue development) and other unwanted feminization. Winlevi works locally and doesn't have these effects, making it the first hormonal acne option viable for males. Second, it avoids the contraception requirement that spironolactone imposes on women of reproductive potential. Third, it can be used in teenagers (12+) where systemic spironolactone is rarely first-line. Fourth, it can be combined with topical retinoids and antibiotics without significant drug-drug interactions.
The trade-offs: cost ($600+/tube without insurance, often less with copay assistance), the need for twice-daily application, and effectiveness similar but not dramatically superior to standard combinations. For women with significant hormonal acne who can take spironolactone, the oral medication is usually more cost-effective and often more effective overall. For men with hormonal acne patterns, Winlevi is one of the few good options outside of isotretinoin.
A typical regimen for hormonal acne might use Winlevi BID + tretinoin nightly + benzoyl peroxide wash daily, with the option to add oral spironolactone (women) or escalate to other treatments if needed.
Why local androgen blockade matters
Sebaceous glands express androgen receptors that, when activated by testosterone or dihydrotestosterone, increase sebum production. Blocking these receptors reduces sebum output and downstream inflammation. Spironolactone achieves this systemically, affecting androgen receptors throughout the body — a feature in some patients (also helps with hirsutism), a bug in others (gynecomastia in men, contraception requirements in women).
Clascoterone's topical action localizes the effect to the skin where it's applied. Sebum production decreases at the application site; circulating hormone levels are essentially unchanged. This makes the medication broadly safer but limits effectiveness to areas you can apply it (face, chest, back) and requires twice-daily compliance.
Treatment options a doctor may consider
- Winlevi (clascoterone 1%) cream BID
Apply morning and evening to affected areas. 12 weeks for full effect.
- Spironolactone 50-100mg daily (women)
Oral alternative. More effective for many patients, requires contraception. Lower cost.
- Winlevi + spironolactone combination
For severe hormonal acne in women — local and systemic blockade together.
- Layer with tretinoin and benzoyl peroxide
Standard combination foundation. Hormonal treatment doesn't replace topical maintenance.
Your specific regimen depends on your medical history, current medications, and intake photos. Only your physician can determine what's appropriate.
Who this applies to
Men with hormonal acne patterns (spironolactone alternative), women wanting topical hormonal treatment without contraception requirements, teens with hormonal acne, and anyone with contraindications to oral spironolactone.